These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 9522849

  • 41. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [2-year anti-HIV donor screening in the Central Laboratory of the Swiss Red Cross Blood Transfusion Service].
    Lang O, Bachmann P, Baumgartner C, Bütler R.
    Schweiz Med Wochenschr; 1988 Apr 16; 118(15):547-53. PubMed ID: 3375791
    [Abstract] [Full Text] [Related]

  • 44. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G, Seed CR, Wang F, Nie D, Farrugia A.
    Transfusion; 2007 Mar 16; 47(3):529-39. PubMed ID: 17319836
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.
    Transfusion; 2007 Feb 16; 47(2):316-25. PubMed ID: 17302779
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Economics of blood screening: in search of an optimal blood screening strategy.
    Chinkhumba J.
    Trop Doct; 2006 Jan 16; 36(1):32-4. PubMed ID: 16483429
    [Abstract] [Full Text] [Related]

  • 50. Infectious markers in blood donors of East Delhi: prevalence and trends.
    Singh B, Kataria SP, Gupta R.
    Indian J Pathol Microbiol; 2004 Oct 16; 47(4):477-9. PubMed ID: 16295370
    [Abstract] [Full Text] [Related]

  • 51. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL, Saguier MC, Salamone HJ.
    Sangre (Barc); 1999 Jun 16; 44(3):240-1. PubMed ID: 10481590
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Risk of infection in hemotherapy].
    Sibrowski W, Wüllenweber J.
    Infusionsther Transfusionsmed; 1994 Aug 16; 21 Suppl 1():60-3. PubMed ID: 8000255
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Current issues in blood component therapy: transmission of infectious diseases.
    Menitove JE.
    Oncology (Williston Park); 1987 Jun 16; 1(4):21-30. PubMed ID: 2856350
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.